Attempts to contain Marburg disease epidemic have limited effect

doi:10.1136/bmj.330.7496.864-a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Chibuzo Odigwe

Calabar, Nigeria

An outbreak of Marburg haemorrhagic fever in Angola that has so far affected 205 people, killing 180 of them, does not yet seem to be under control despite high level international efforts. The disease is rare, has a high mortality, and has no vaccine or treatment. It had not been seen in Angola before this epidemic began in late 2004.

The latest number of deaths was announced in a statement released last Friday by the World Health Organization. WHO has also launched an appeal, through the United Nations, for funding to support the emergency response to the outbreak. WHO needs $2.4m (£1.3m; €1.9m) to support the Ministry of Health in Angola to intensify ongoing operations in the field. …